The authors used a disposable original system to recover total blood during surgery and realized 17 transfusions of autologous blood in sheep. No biological or clinical disturbance was observed.
Download full-text PDF |
Source |
---|
Transfusion
January 2025
Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Background: Neonates with congenital anomalies frequently require perioperative allogeneic red blood cell (RBC) transfusion. Whole cord blood for autologous transfusion to neonates may provide an alternative RBC source, but whether sufficient volumes can be collected after delayed cord clamping to reduce allogeneic RBC requirements is unknown.
Study Design And Methods: Inclusion criteria were mothers delivering a viable infant >34 weeks' gestation.
Transfus Med Hemother
December 2024
Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Background: The use of cell salvage and autologous blood transfusion is an important and widespread method of blood conservation during surgeries with expected high blood loss. The continuous autotransfusion device CATSmart (Fresenius Kabi, Germany) contains two new washing programs on the device called Flex wash 3 and Flex wash 5. To the best of our knowledge, there are no published clinical data regarding the performance of the two new washing programs.
View Article and Find Full Text PDFCureus
October 2024
Department of Anesthesiology, Uniformed Services University of the Health Sciences, Bethesda, USA.
J Trauma Acute Care Surg
October 2024
From the Department of Surgery (P.G., A.S., D.D., P.D.), Louisiana State University Health Science Center, New Orleans, LA; Department of Surgery (A.C.), University of Tennessee Graduate School of Medicine, Knoxville, TN; Department of Molecular Pharmacology and Physiology (T.S.), University of South Florida, Tampa, FL; School of Medicine (O.W., J.D., A.S.), Louisiana State University Health Science Center, New Orleans, LA; Tulane University School of Medicine (M.C.G., T.C.B.), New Orleans, LA; and Department of Emergency Medicine (K.V.), Louisiana State University Health Science Center, New Orleans, LA.
Expert Opin Biol Ther
September 2024
Department of Hematology/Oncology, Children's University Hospital, Tübingen, Germany.
Introduction: Sickle cell disease is the most common hereditary hemoglobinopathy followed by beta-thalassemia. Until recently, allogeneic stem cell transplantation was the only curative approach. Based on the Crispr-Cas9-technology enabling targeting specific genes of interest, fetal hemoglobin which is normally shut-off after birth can be switched on and sufficient levels can alleviate symptoms in sickle cell disease and avoid transfusions in beta-thalassemia.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!